Negocie Bristol Myers BMY

Gráfico BristolMyers ao vivo

Fundamentos do instrumento

Weekly Search
Weekly
Daily
Data Fechar Mudança Alteração (%): Abertura Max Min

BristolMyers news

Magnificent 7 earnings, US and Japan inflation due next week
Neil Wilson 2024 Jul 18, 16:00

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Forex Indices
Wall Street earnings
Neil Wilson 2023 Oct 20, 10:00

Week ahead: Earnings bonanza, ECB decision & US inflation

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

2022 Jul 24, 05:42

Week ahead: Fed to hike 100bps into a recession?

Últimas notícias

Mostrar mais
Liam James 2025 Aug 22, 15:20

Market Review & Investment Insights: August 2025

Noah Lee 2025 Aug 22, 15:20

Trump Threatens to Fire Fed Governor Lisa Cook Amid Mortgage Fraud Allegations

Liam James 2025 Aug 22, 15:20

Wall Street Reacts: Powell Hints at September Rate Cut, But Cautiously

Liam James 2025 Aug 22, 14:20

Dollar Bullish Sentiment Rises Ahead of Powell Speech, Forex Options Show

Ava Grace 2025 Aug 22, 12:20

Syria to Revalue Currency: Removing Zeros in Bid to Restore Confidence

Noah Lee 2025 Aug 22, 10:20

India, Russia Expand Trade Amid US Tariff Pressure

Ava Grace 2025 Aug 22, 08:20

Trump Administration Eyes Repurposing Chip Act Funds for Critical Minerals

Emma Rose 2025 Aug 22, 08:20

Powell's Jackson Hole Speech: Shaping the Fed's Future Amidst Economic Uncertainty

Info

Spread

0.29

Spread (%)

0.6081 %

Alavancagem

1:10

Juro overnight, Compra

-0.0597 %

Juro overnight, Venda

-0.0292 %

Moeda

USD

Horários de Negociação

Mercados fechados

Segunda-feira

13:31 - 19:59

Terça-feira

13:31-19:59

Quarta-feira

13:31-19:59

Quinta-feira

13:31-19:59

Sexta-feira

13:31-19:59

Análise e estatística

Abertura

---

Fechamento anterior

---

Alta/baixa em 52 semanas

--- – ---

Capitalização de mercado

97538277376

Ações em circulação

2035440000

Data dos rendimentos (Próxima)

2001-08-07

Rendim Divid

2025-08-01

Data Ex-Dividendos

2025-07-03

Taxa anual futura de dividendos

2.48

Rendimento anual futuro de dividendos

0.0512

EPS

2.49

Saiba mais sobre este instrumento

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Instrumentos relacionados

Ativo
Venda
Comprar
Alteração (%):
Instrumentos relacionados

latest_education_articles

Mostrar mais
Trustpilot